Fiche publication
Date publication
septembre 2019
Journal
Neuropsychobiology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr SAULEAU Erik-André
,
Dr NOBLET Vincent
Tous les auteurs :
Foucher JR, de Billy C, Jeanjean LC, Obrecht A, Mainberger O, Clauss JME, Schorr B, Lupu MC, de Sousa PL, Lamy J, Noblet V, Sauleau EA, Landré L, Berna F
Lien Pubmed
Résumé
Periodic catatonia (PC) is a psychomotor phenotype with a progressive-remitting course. While it can fit any disorder diagnosis of the schizoaffective spectrum, its core features consist of a mix of hypo- and hyperkinesias resulting in distortions of expressive movements such as grimacing and parakinesias. The replication of cerebral blood flow (CBF) increases in the left supplementary motor area (L-SMA) and lateral premotor cortex (L-LPM) in acute and remitting PC patients indicates that these increases could be used as diagnostic biomarkers. In this proof-of-concept study, 2 different MRI sequences were repeated on 3 separate days to get reliable measurement values of CBF in 9 PC and 26 non-PC patients during different cognitive tasks. Each patient was compared to 37 controls. In L-SMA [-9; +10; +60] and L-LPM [-46; -12; +43], a test was positive if the t value was >2.02 (α < 0.05; two tailed). The measurements had good analytical performance. Regarding the tests, their sensitivities and specificities were significantly different from the chance level on both measures, except for L-SMA sensitivities. When combining all the tests, among regions and methods, sensitivity was 98% (95% credible interval [CI] 76-100%) and specificity 88% (72-97%). Bayesian inferences of its negative predictive values for PC were >95% regardless of the context, while its positive predictive values reached 94% but only when used in combination with clinical criteria. The case-by-case analysis suggests that non-PC patients with neurological motor deficits are at risk to be false positive.
Mots clés
Biomarkers, Endogenous psychoses, Functional brain imaging, Periodic catatonia, Regional cerebral blood flow, Schizophrenia
Référence
Neuropsychobiology. 2019 Sep 10;:1-14